{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:32:15Z","timestamp":1791869535707,"version":"4.3.4"},"reference-count":37,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>This multicenter, open-label, randomized trial examined the safety and efficacy of exenatide alone or in combination with basal insulin in non\u2013critically ill patients with type 2 diabetes (T2D).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>A total of 150 patients with blood glucose (BG) between 140 and 400 mg\/dL, treated at home with diet, oral agents, or insulin at a total daily dose &amp;lt;0.5 units\/kg, were randomized to exenatide alone (5 \u03bcg twice daily), exenatide plus basal insulin, or a basal-bolus insulin regimen. The primary end point was difference in mean daily BG concentration among groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Mean daily BG was similar between patients treated with exenatide plus basal and a basal-bolus regimen (154 \u00b1 39 vs. 166 \u00b1 40 mg\/dL, P = 0.31), and exenatide plus basal resulted in lower daily BG than did exenatide alone (177 \u00b1 41 mg\/dL, P = 0.02). Exenatide plus basal resulted in a higher proportion of BG levels in target range between 70 and 180 mg\/dL compared with exenatide and basal-bolus (78% vs. 62% vs. 63%, respectively, P = 0.023). More patients in the exenatide and exenatide plus basal groups experienced nausea or vomiting than in the basal-bolus group (10% vs. 11% vs. 2%, P = 0.17), with three patients (6%) discontinued exenatide owing to adverse events. There were no differences in hypoglycemia &amp;lt;54 mg\/dL (2% vs. 0% vs. 4%, P = 0.77) or length of stay (5 vs. 4 vs. 4 days, P = 0.23) among basal plus exenatide, exenatide, and basal-bolus groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The results of this pilot study indicate that exenatide alone or in combination with basal insulin is safe and effective for the management of hospitalized general medical and surgical patients with T2D.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc18-1760","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T21:05:51Z","timestamp":1548363951000},"page":"450-456","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":77,"title":["A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes"],"prefix":"10.2337","volume":"42","clinical-trial-number":[{"clinical-trial-number":"nct02455076","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-3160","authenticated-orcid":false,"given":"Maya","family":"Fayfman","sequence":"first","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-3225","authenticated-orcid":false,"given":"Rodolfo J.","family":"Galindo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Temple University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara L.","family":"Mize","sequence":"additional","affiliation":[{"name":"School of Medicine, Vanderbilt University, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Anzola","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Urrutia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementina","family":"Ramos","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Pasquel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Sonya","family":"Haw","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyathama","family":"Vellanki","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heqiong","family":"Wang","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie S.","family":"Albury","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Weaver","sequence":"additional","affiliation":[{"name":"School of Medicine, Vanderbilt University, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumeth","family":"Cardona","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3252-5026","authenticated-orcid":false,"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"2022031300184153800_B1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"87","author":"Umpierrez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300184153800_B2","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/jama.290.15.2041","article-title":"Glucose control and mortality in critically ill patients","volume":"290","author":"Finney","year":"2003","journal-title":"JAMA"},{"key":"2022031300184153800_B3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.CCM.0000045568.12881.10","article-title":"Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control","volume":"31","author":"Van den Berghe","year":"2003","journal-title":"Crit Care Med"},{"key":"2022031300184153800_B4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/014860719802200277","article-title":"Early postoperative glucose control predicts nosocomial infection rate in diabetic patients","volume":"22","author":"Pomposelli","year":"1998","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2022031300184153800_B5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/archinternmed.2008.593","article-title":"Glucose normalization and outcomes in patients with acute myocardial infarction","volume":"169","author":"Kosiborod","year":"2009","journal-title":"Arch Intern Med"},{"key":"2022031300184153800_B6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mtc.2003.181","article-title":"Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting","volume":"125","author":"Furnary","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2022031300184153800_B7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2337\/diacare.27.2.553","article-title":"Management of diabetes and hyperglycemia in hospitals","volume":"27","author":"Clement","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031300184153800_B8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP09102.RA","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"15","author":"Moghissi","year":"2009","journal-title":"Endocr Pract"},{"key":"2022031300184153800_B9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031300184153800_B10","first-page":"360","article-title":"Iatrogenic hypoglycemia secondary to tight glucose control is an independent determinant for mortality and cardiac morbidity","volume":"40","author":"D\u2019Ancona","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"2022031300184153800_B11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4065\/mcp.2009.0394","article-title":"Hypoglycemia and outcome in critically ill patients","volume":"85","author":"Egi","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"2022031300184153800_B12","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.2009.496","article-title":"Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction","volume":"301","author":"Kosiborod","year":"2009","journal-title":"JAMA"},{"key":"2022031300184153800_B13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300184153800_B14","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.2337\/dc18-S014","article-title":"14. Diabetes care in the hospital: Standards of Medical Care in Diabetes\u20142018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031300184153800_B15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1210\/jc.2011-2100","article-title":"Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis","volume":"97","author":"Murad","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300184153800_B16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/dc06-1715","article-title":"Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals","volume":"30","author":"Wexler","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031300184153800_B17","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/dc12-1988","article-title":"Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: Basal Plus trial","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031300184153800_B18","doi-asserted-by":"crossref","first-page":"e000394","DOI":"10.1136\/bmjdrc-2017-000394","article-title":"Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients","volume":"5","author":"Garg","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2022031300184153800_B19","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.2337\/dc13-0277","article-title":"Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031300184153800_B20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4158\/EP-2018-0036","article-title":"The efficacy and safety of co-administration of sitagliptin with metformin in patients with type 2 diabetes at hospital discharge","volume":"24","author":"Gianchandani","year":"2018","journal-title":"Endocr Pract"},{"key":"2022031300184153800_B21","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2337\/dc12-2060","article-title":"Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes? The time has come for GLP-1 receptor agonists!","volume":"36","author":"Schwartz","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031300184153800_B22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","article-title":"Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial","volume":"5","author":"Pasquel","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031300184153800_B23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/17425255.2013.731394","article-title":"GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations","volume":"9","author":"Jespersen","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2022031300184153800_B24","doi-asserted-by":"crossref","first-page":"E1209","DOI":"10.1152\/ajpendo.00237.2004","article-title":"Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease","volume":"287","author":"Nystr\u00f6m","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031300184153800_B25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.amjcard.2007.05.022","article-title":"Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting","volume":"100","author":"Sokos","year":"2007","journal-title":"Am J Cardiol"},{"key":"2022031300184153800_B26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s00125-011-2440-x","article-title":"Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety","volume":"55","author":"Nathanson","year":"2012","journal-title":"Diabetologia"},{"key":"2022031300184153800_B27","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"2022031300184153800_B28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1503\/cmaj.090206","article-title":"Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data","volume":"180","author":"Griesdale","year":"2009","journal-title":"CMAJ"},{"key":"2022031300184153800_B29","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s00134-009-1585-2","article-title":"A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study","volume":"35","author":"Preiser","year":"2009","journal-title":"Intensive Care Med"},{"key":"2022031300184153800_B30","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2337\/dc09-9029","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"32","author":"Moghissi","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031300184153800_B31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1463-1326.2010.01212.x","article-title":"Pharmacokinetics of dipeptidylpeptidase-4 inhibitors","volume":"12","author":"Scheen","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"2022031300184153800_B32","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.2337\/dc13-0277","article-title":"Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031300184153800_B33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4158\/EP12196.OR","article-title":"Management of hyperglycemia with the administration of intravenous exenatide to patients in the cardiac intensive care unit","volume":"19","author":"Abuannadi","year":"2013","journal-title":"Endocr Pract"},{"key":"2022031300184153800_B34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/ALN.0000000000001838","article-title":"Clinical effectiveness of intravenous exenatide infusion in perioperative glycemic control after coronary artery bypass graft surgery: a phase II\/III randomized trial","volume":"127","author":"Besch","year":"2017","journal-title":"Anesthesiology"},{"key":"2022031300184153800_B35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/anae.14180","article-title":"Peri-operative management of patients with type-2 diabetes mellitus undergoing non-cardiac surgery using liraglutide, glucose-insulin-potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial","volume":"73","author":"Polderman","year":"2018","journal-title":"Anaesthesia"},{"key":"2022031300184153800_B36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1475-2840-11-107","article-title":"Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes","volume":"11","author":"Fujishima","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"2022031300184153800_B37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1475-2840-10-109","article-title":"Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes","volume":"10","author":"Inoue","year":"2011","journal-title":"Cardiovasc Diabetol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc18-1760","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/3\/450\/528538\/dc181760.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/3\/450\/528538\/dc181760.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:31:48Z","timestamp":1647142308000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/3\/450\/36122\/A-Randomized-Controlled-Trial-on-the-Safety-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,1,24]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-1760","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]}}}